Natco Pharma Limited — Oseltamivir Exporter Profile
Indian Pharmaceutical Exporter · #1 for Oseltamivir · $8.8M export value · DGFT Verified
Natco Pharma Limited is the #1 Indian exporter of Oseltamivir with $8.8M in export value and 176 verified shipments. Natco Pharma Limited holds a 7.2% market share in Oseltamivir exports across 7 countries. The company exports 17 pharmaceutical products worth $36.0M across 6 therapeutic categories.
Natco Pharma Limited — Oseltamivir Export Profile: Buyers & Destinations
Where Does Natco Pharma Limited Export Oseltamivir?
| Country | Value | Shipments | Share |
|---|---|---|---|
| CANADA | $3.8M | 76 | 49.7% |
| CHINA | $2.3M | 46 | 30.4% |
| BRAZIL | $830.4K | 31 | 11.0% |
| HONG KONG | $324.0K | 12 | 4.3% |
| MALAYSIA | $312.3K | 9 | 4.1% |
| SAUDI ARABIA | $38.4K | 1 | 0.5% |
| OMAN | $3.1K | 1 | 0.0% |
Natco Pharma Limited exports Oseltamivir to 7 countries. The largest destination is CANADA accounting for 49.7% of Natco Pharma Limited's Oseltamivir shipments, followed by CHINA (30.4%) and BRAZIL (11.0%). These destinations reflect Natco Pharma Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Oseltamivir from Natco Pharma Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| NATCO PHARMA (CANADA) INC | CANADA | $2.9M | 59 |
| CHONGQING PHARMACEUTICAL (GROUP) CO | CHINA | $700.0K | 14 |
| CHONGQING PHARMACEUTICAL GROUP | CHINA | $650.0K | 13 |
| CHONGQING PHARMACEUTICAL(GROUP) CO. | CHINA | $500.0K | 10 |
| NATCO PHARMA (CANADA)INC | CANADA | $400.0K | 8 |
| NATCO PHARMA CANADA INC | CANADA | $400.0K | 8 |
| PERNIAGAAN NORMAHAS SDN BHD | MALAYSIA | $312.3K | 9 |
| CHONGQING PHARMACEUTICAL (GROUP) CO LIMITED | CHINA | $300.0K | 6 |
| NATCOFARMA DO BRASIL LTDA | BRAZIL | $218.3K | 6 |
| NATCOFARMA DO BRASIL LTDA, | BRAZIL | $214.0K | 6 |
Natco Pharma Limited supplies Oseltamivir to 23 buyers globally. The largest buyer is NATCO PHARMA (CANADA) INC (CANADA), followed by CHONGQING PHARMACEUTICAL (GROUP) CO (CHINA) and CHONGQING PHARMACEUTICAL GROUP (CHINA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Oseltamivir Export Value and How Much Does Natco Pharma Limited Contribute?
India exported $62.0M worth of Oseltamivir through 2,149 shipments from 118 suppliers to 79 countries, serving 314 buyers globally. Natco Pharma Limited contributes $8.8M to this total, accounting for 7.2% of India's Oseltamivir exports. Natco Pharma Limited ships Oseltamivir to 7 countries through 23 buyers.
What Is the Average Shipment Value for Natco Pharma Limited's Oseltamivir Exports?
Natco Pharma Limited's average Oseltamivir shipment value is $50.0K per consignment, based on 176 shipments totaling $8.8M. The largest destination is CANADA (49.7% of Natco Pharma Limited's Oseltamivir exports).
How Does Natco Pharma Limited Compare to Other Indian Oseltamivir Exporters?
Natco Pharma Limited ranks #1 among 118 Indian Oseltamivir exporters with a 7.2% market share. The top 3 exporters are MSN LABORATORIES PRIVATE LIMITED ($12.3M), HETERO LABS LIMITED ($12.0M), LUPIN LIMITED ($9.0M). Natco Pharma Limited processed 176 shipments to 7 destination countries.
What Oseltamivir Formulations Does Natco Pharma Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| NAT-OSELTAMIVIR PHOSPHATE 75MG CAPSULES | $750.0K | 15 |
| NAT-OSELTAMIVIR PHOSPHATE 75 MG CAPSULES | $350.0K | 7 |
| OSELTAMIVIR PHOSPHATE CAPSULES 75 MG 10S | $250.0K | 5 |
| NATFLU CAPSULES 75MG 10S(OSELTAMIVIR PHO | $200.0K | 4 |
| OSELTAMIVIR PHOSPHATE CAPSULES 75 MG (96 | $200.0K | 4 |
| NAT-OSELTAMIVIR PHOSPHATE 30 MG CAPSULES | $192.5K | 4 |
| OSELTAMIVIR PHOSPHATE CAPSULES 30MG (10S | $150.0K | 3 |
| OSELTAMIVIR PHOSPHATE CAPSULES 30MG 10S 72384 X 10S OTHER REF CI NO: 123161APPENDIX 4R, RODTEP ENTRY NO: 10153 | $150.0K | 3 |
| OSELTAMIVIR PHOSPHATE CAPSULES 30MG 10S 70464X 10S OTHER REF CI NO: 123162APPENDIX 4R, RODTEP ENTRY NO: 10153 | $150.0K | 3 |
| OSELTAMIVIR PHOSPHATE CAPSULES 30MG 10S 72384X 10S OTHER REF CI NO: 123163APPENDIX 4R, RODTEP ENTRY NO: 10153 | $150.0K | 3 |
Natco Pharma Limited exports 107 distinct Oseltamivir formulations including tablets, capsules, syrups, and combination drugs. The top formulation is NAT-OSELTAMIVIR PHOSPHATE 75MG CAPSULES with 15 shipments worth $750.0K.
Regulatory Requirements: Exporting Oseltamivir to Key Markets
What Natco Pharma Limited must comply with to export Oseltamivir to its top destination countries
Canada — HC
Approval Process
ANDS (Abbreviated New Drug Submission) referencing Canadian Reference Product. Comparative bioavailability study required.
Timeline: 12–18 months
GMP & Export Requirements
Health Canada GMP (GUI-0001); Drug Establishment Licence (DEL) inspection
Drug Identification Number (DIN) for each product; Certificate of Pharmaceutical Product from CDSCO
Note: Subject to Good Import Practices and annual C.01.014.6 review.
Brazil — ANVISA
Approval Process
Generic registration under RDC 200/2017. ANVISA GMP inspection of Indian facility mandatory before approval.
Timeline: 12–24 months
GMP & Export Requirements
ANVISA GMP certificate (CBPF) for each manufacturing site; on-site inspection by ANVISA
Certificate of Pharmaceutical Product from CDSCO; Import Authorization via SISCOMEX
Note: ANVISA maintains active Indian pharma facility inspection program. Inspection backlog can extend timelines.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Natco Pharma Limited Compare to Nearest Oseltamivir Exporters?
Exporters ranked immediately above and below #1 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | HETERO LABS LIMITED | $12.0M | 240 | 24 | $50.0K |
| 5 | LUPIN LIMITED | $9.0M | 184 | 4 | $48.8K |
| 1 | NATCO PHARMA LIMITED ★ | $8.8M | 176 | 7 | $50.0K |
| 8 | MACLEODS PHARMACEUTICALS LTD | $4.6M | 92 | 12 | $50.0K |
| 6 | ZYDUS LIFESCIENCES LIMITED | $3.8M | 75 | 1 | $50.0K |
Natco Pharma Limited ranks #1 among 118 Indian Oseltamivir exporters. Average shipment value of $50.0K compared to the market average of $525.7K. The closest competitors by value are HETERO LABS LIMITED and LUPIN LIMITED.
Which Indian Ports Ship Oseltamivir Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 348 | 16.2% |
| CHENNAI AIR CARGO ACC (INMAA4) | 201 | 9.4% |
| HYDERABAD ACC (INHYD4) | 182 | 8.5% |
| SAHAR AIR | 151 | 7.0% |
| HYDERABAD ICD (INSNF6) | 129 | 6.0% |
| CHENNAI AIR | 125 | 5.8% |
| HYDERABAD ICD | 119 | 5.5% |
| HYDERABAD AIR | 108 | 5.0% |
Geopolitical & Trade Policy Impact on Natco Pharma Limited's Oseltamivir Exports
Natco's export operations are currently navigating a complex geopolitical landscape. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, resulting in increased freight costs and extended transit times. These challenges are particularly impactful for time-sensitive pharmaceutical shipments, necessitating strategic adjustments in logistics and supply chain management. (pharmaceuticalcommerce.com)
In the United States, recent tariff implementations have introduced additional complexities for Indian pharmaceutical exporters. The U.S. administration's imposition of tariffs on imports from various countries, including India, has raised concerns about the competitiveness of Indian generics in the U.S. market. These tariffs could potentially erode profit margins and affect pricing strategies. (apnews.com)
Conversely, the European Union's stringent regulatory changes, such as the Falsified Medicines Directive, have heightened compliance requirements for exporters. While these regulations aim to ensure product authenticity and safety, they also necessitate significant investments in serialization and traceability systems. For companies like Natco, adhering to these standards is crucial for maintaining access to the lucrative EU market.
Natco Pharma Limited — Regulatory Compliance & Quality Standards
The global pharmaceutical industry is witnessing intensified scrutiny regarding quality and compliance. The U.S. Food and Drug Administration (FDA) has increased inspections of Indian manufacturing facilities, emphasizing adherence to Good Manufacturing Practices (GMP). Non-compliance can lead to warning letters, import alerts, or even bans, posing significant risks to exporters. (fact.net.in)
Natco's commitment to quality is evident in its proactive measures to meet international standards. The company's recent product approvals and successful market entries suggest a robust compliance framework. However, continuous vigilance and investment in quality systems are imperative to navigate the evolving regulatory landscape and to sustain export growth.
About Natco Pharma Limited
Natco Pharma Limited exports 17 products worth $36.0M. Beyond Oseltamivir, top products include Everolimus, Apixaban, Anastrozole, Ondansetron, Imatinib. View the complete Natco Pharma Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Oseltamivir — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Oseltamivir shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Natco Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 176 individual customs records matching Natco Pharma Limited exporting Oseltamivir, covering 107 formulations to 7 countries via 23 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 79+ countries, 314+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Oseltamivir Export Data from Natco Pharma Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Natco Pharma Limited's Oseltamivir exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Natco Pharma Limited
Full Company Profile →
17 products · $36.0M total trade · 6 categories
Oseltamivir Stats
Company Overview
Top Products by Natco Pharma Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Natco Pharma Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Oseltamivir. For current shipment-level data, contact TransData Nexus.